Periodic Reporting for period 3 - BioMensio (BioMensio mobile biosensing platform: the first truly palm-sized and accurate digital multi-drug test)
Reporting period: 2021-05-01 to 2022-03-31
The conclusions of the project:
- A bioassay for milk quality monitoring has been developed and validated on our lab analyser
- Drugs of Abuse application has also been developed during the project and is planned to be commercialized after the initial milk quality monitoring application
- Piloting study on milk quality monitoring is scheduled
- A process for biofunctionalization of sensors has been developed
- A process for mass manufacturing of the sensor is in the process of been set – this will bring COGS significantly down
- A new cartridge and reader for piloting study have been developed and are in the process of been validated
Work Package 2 focuses on development of sensor, cartridge and hardware. Significant efforts have been put in improving sensor manufacturing process, overall quality and yield. A process for mass manufacturing is been set. Cartridge and reader for food monitoring and drugs of abuse screening have been developed and will be verified during coming months.
A piloting study (Work Package 3) on food safety has been planned for the end of the 2022.
Work Package 4: Commercialisation plan, website and social media profiles are continuously updated. IP rights have been transferred from the founders to Biomensio in spring 2021. Processes to establish high quality mass manufacturing are being set. Pandemic has prevented technology demonstrations and networking during 2020-21, however, currently we are actively preparing product and technology demonstrations and are looking for new industrial partners. Several dissemination articles are in preparation.
In Work Package 5: all deliverables have been submitted and overall goal achieved.